Your browser doesn't support javascript.
loading
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Maher, Toby M; van der Aar, Ellen M; Van de Steen, Olivier; Allamassey, Lisa; Desrivot, Julie; Dupont, Sonia; Fagard, Liesbeth; Ford, Paul; Fieuw, Ann; Wuyts, Wim.
Afiliación
  • Maher TM; NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK; Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK. Electronic address: t.maher@rbht.nhs.uk.
  • van der Aar EM; Galapagos, Mechelen, Belgium.
  • Van de Steen O; Galapagos, Mechelen, Belgium.
  • Allamassey L; Alten, Brussels, Belgium.
  • Desrivot J; Galapagos, Romainville, France.
  • Dupont S; Galapagos, Romainville, France.
  • Fagard L; Galapagos, Mechelen, Belgium.
  • Ford P; Galapagos, Mechelen, Belgium.
  • Fieuw A; Galapagos, Mechelen, Belgium.
  • Wuyts W; Unit for Interstitial Lung Diseases, Department of Pulmonary Medicine, University Hospitals Leuven, Leuven, Belgium.
Lancet Respir Med ; 6(8): 627-635, 2018 08.
Article en En | MEDLINE | ID: mdl-29792287

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Fibrosis Pulmonar Idiopática / Imidazoles Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Fibrosis Pulmonar Idiopática / Imidazoles Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2018 Tipo del documento: Article